상세 보기
Survival benefit of Olaparib in 1st-line advanced ovarian cancer as a monotherapy & in combination with bevacizumab
- 제목
- Survival benefit of Olaparib in 1st-line advanced ovarian cancer as a monotherapy & in combination with bevacizumab
- 저자
- 배재만
- 발행일
- 2024-11-16
- 학회명
- KGOG 2024 Fall Semi-Annual Meeting
- 개최지
- 송도 연세대학교 국제캠퍼스